BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 12728043)

  • 1. Effect of regional gene therapy with bone morphogenetic protein-2-producing bone marrow cells on spinal fusion in rats.
    Wang JC; Kanim LE; Yoo S; Campbell PA; Berk AJ; Lieberman JR
    J Bone Joint Surg Am; 2003 May; 85(5):905-11. PubMed ID: 12728043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of regional gene therapy with bone morphogenetic protein-2-producing bone-marrow cells on the repair of segmental femoral defects in rats.
    Lieberman JR; Daluiski A; Stevenson S; Wu L; McAllister P; Lee YP; Kabo JM; Finerman GA; Berk AJ; Witte ON
    J Bone Joint Surg Am; 1999 Jul; 81(7):905-17. PubMed ID: 10428121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetically modified human derived bone marrow cells for posterolateral lumbar spine fusion in athymic rats: beyond conventional autologous bone grafting.
    Peterson B; Iglesias R; Zhang J; Wang JC; Lieberman JR
    Spine (Phila Pa 1976); 2005 Feb; 30(3):283-9; discussion 289-90. PubMed ID: 15682007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of lentiviral and adenoviral gene therapy for spinal fusion in rats.
    Miyazaki M; Sugiyama O; Zou J; Yoon SH; Wei F; Morishita Y; Sintuu C; Virk MS; Lieberman JR; Wang JC
    Spine (Phila Pa 1976); 2008 Jun; 33(13):1410-7. PubMed ID: 18475244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of lentiviral gene therapy with bone morphogenetic protein-2-producing bone marrow cells on spinal fusion in rats.
    Miyazaki M; Sugiyama O; Tow B; Zou J; Morishita Y; Wei F; Napoli A; Sintuu C; Lieberman JR; Wang JC
    J Spinal Disord Tech; 2008 Jul; 21(5):372-9. PubMed ID: 18600149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of human mesenchymal stem cells derived from adipose tissue and bone marrow for ex vivo gene therapy in rat spinal fusion model.
    Miyazaki M; Zuk PA; Zou J; Yoon SH; Wei F; Morishita Y; Sintuu C; Wang JC
    Spine (Phila Pa 1976); 2008 Apr; 33(8):863-9. PubMed ID: 18404105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stem cells from human fat as cellular delivery vehicles in an athymic rat posterolateral spine fusion model.
    Hsu WK; Wang JC; Liu NQ; Krenek L; Zuk PA; Hedrick MH; Benhaim P; Lieberman JR
    J Bone Joint Surg Am; 2008 May; 90(5):1043-52. PubMed ID: 18451397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A porcine collagen-derived matrix as a carrier for recombinant human bone morphogenetic protein-2 enhances spinal fusion in rats.
    Miyazaki M; Morishita Y; He W; Hu M; Sintuu C; Hymanson HJ; Falakassa J; Tsumura H; Wang JC
    Spine J; 2009; 9(1):22-30. PubMed ID: 18805060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. rhBMP-6 stimulated osteoprogenitor cells enhance posterolateral spinal fusion in the New Zealand white rabbit.
    Valdes M; Moore DC; Palumbo M; Lucas PR; Robertson A; Appel J; Ehrlich MG; Keeping HS
    Spine J; 2007; 7(3):318-25. PubMed ID: 17482115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of Healos/bone marrow to INFUSE(rhBMP-2/ACS) with a collagen-ceramic sponge bulking agent as graft substitutes for lumbar spine fusion.
    Kraiwattanapong C; Boden SD; Louis-Ugbo J; Attallah E; Barnes B; Hutton WC
    Spine (Phila Pa 1976); 2005 May; 30(9):1001-7; discussion 1007. PubMed ID: 15864149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simple carrier matrix modifications can enhance delivery of recombinant human bone morphogenetic protein-2 for posterolateral spine fusion.
    Akamaru T; Suh D; Boden SD; Kim HS; Minamide A; Louis-Ugbo J
    Spine (Phila Pa 1976); 2003 Mar; 28(5):429-34. PubMed ID: 12616152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The osteoinductive properties of Nell-1 in a rat spinal fusion model.
    Lu SS; Zhang X; Soo C; Hsu T; Napoli A; Aghaloo T; Wu BM; Tsou P; Ting K; Wang JC
    Spine J; 2007; 7(1):50-60. PubMed ID: 17197333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experimental spinal fusion using sintered bovine bone coated with type I collagen and recombinant human bone morphogenetic protein-2.
    Minamide A; Tamaki T; Kawakami M; Hashizume H; Yoshida M; Sakata R
    Spine (Phila Pa 1976); 1999 Sep; 24(18):1863-70; discussion 1871-2. PubMed ID: 10515009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Posterolateral lumbar intertransverse process spine arthrodesis with recombinant human bone morphogenetic protein 2/hydroxyapatite-tricalcium phosphate after laminectomy in the nonhuman primate.
    Boden SD; Martin GJ; Morone MA; Ugbo JL; Moskovitz PA
    Spine (Phila Pa 1976); 1999 Jun; 24(12):1179-85. PubMed ID: 10382242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of carriers of bone morphogenetic protein for spinal fusion.
    Minamide A; Kawakami M; Hashizume H; Sakata R; Tamaki T
    Spine (Phila Pa 1976); 2001 Apr; 26(8):933-9. PubMed ID: 11317116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of bone morphogenetic protein and basic fibroblast growth factor on cultured mesenchymal stem cells for spine fusion.
    Minamide A; Yoshida M; Kawakami M; Okada M; Enyo Y; Hashizume H; Boden SD
    Spine (Phila Pa 1976); 2007 May; 32(10):1067-71. PubMed ID: 17471086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delivery of recombinant human bone morphogenetic protein-2 using a compression-resistant matrix in posterolateral spine fusion in the rabbit and in the non-human primate.
    Suh DY; Boden SD; Louis-Ugbo J; Mayr M; Murakami H; Kim HS; Minamide A; Hutton WC
    Spine (Phila Pa 1976); 2002 Feb; 27(4):353-60. PubMed ID: 11840099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An in vitro and in vivo analysis of fibrin glue use to control bone morphogenetic protein diffusion and bone morphogenetic protein-stimulated bone growth.
    Patel VV; Zhao L; Wong P; Pradhan BB; Bae HW; Kanim L; Delamarter RB
    Spine J; 2006; 6(4):397-403; discussion 404. PubMed ID: 16825045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of platelet-rich plasma and bone marrow on murine posterolateral lumbar spine arthrodesis with bone morphogenetic protein.
    Rao RD; Gourab K; Bagaria VB; Shidham VB; Metkar U; Cooley BC
    J Bone Joint Surg Am; 2009 May; 91(5):1199-206. PubMed ID: 19411469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant human bone morphogenetic protein-2 enhances anterior spinal fusion in a thoracoscopically instrumented animal model.
    Sucato DJ; Hedequist D; Zhang H; Pierce WA; O'Brien SE; Welch RD
    J Bone Joint Surg Am; 2004 Apr; 86(4):752-62. PubMed ID: 15069140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.